Editor(s):
(1) Dr. Paola Angelini, University of Perugia, Perugia, Italy.
(2) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India.
Reviewers:
(1) Livhuwani Muthelo, University of Limpopo, South Africa.
(2) Surendra Prasad Chaurasiya, Tribhuvan University, Nepal.
(3) Halah H. Al-Haideri, University of Baghdad, Iraq.
Additional Reviewers:
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 7.8/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Livhuwani Muthelo, South Africa) | File 1 | NA
Stage 2 | Peer review report_2 (Surendra Prasad Chaurasiya, Nepal) | File 1 | NA
Stage 2 | Peer review report_3 (Halah H. Al-Haideri, Iraq) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA